Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression

Boeger, Christine, Kalthoff, Holger, Goodman, Simon L., Behrens, Hans-Michael and Roecken, Christoph (2014) Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression Virchows Archiv, 464 (1). pp. 69-78.

Full text not available from this repository.

Abstract

The aim of this study was to investigate the expression of integrins, their ligands, and integrin signaling-related molecules in a cohort of human primary non-small cell lung cancers (NSCLC). Formalin-fixed and paraffin-embedded tissue samples from 215 NSCLC were immunohistochemically stained using antibodies directed against alpha v beta 3, alpha v beta 5, alpha v beta 6, alpha v beta 8, alpha v, osteopontin, fibronectin, vitronectin, epidermal growth factor (EGFR), vascular endothelial growth factor receptor (VEGFR), and Ki67. Immunostaining of tumor, stroma, and endothelial cells was evaluated separately by quantity and intensity (tumor cells) or intensity (stroma and endothelial cells) expressed in an immunoreactivity score. We studied correlations between the staining patterns of the different markers and of marker expression with clinicopathological data and patient survival. In the majority of NSCLC, each marker was expressed in at least one tumor component. As expected, alpha v and alpha v integrin heterodimers were significantly co-expressed, as were integrins and EGFR. Vitronectin was expressed significantly more often in smaller (T-category) and in well-differentiated tumors; Ki67 index was higher in larger (T-category) and in poorly differentiated tumors. No significant correlation was found between any marker expression and gender, venous invasion, lymph vessel invasion, lymph node metastasis, or survival. Although integrin expression does not seem to be associated with indicators of progression of NSCLC, the expression of alpha v beta 3 in 89 % and alpha v beta 5 in 100 % of NSCLC is novel and merits to be further investigated.

Document Type: Article
Additional Information: Times Cited: 4 Rocken, Christoph/A-9239-2010; Kalthoff, Holger/B-1618-2010 Rocken, Christoph/0000-0002-6989-8002; 0 4
Research affiliation: OceanRep > The Future Ocean - Cluster of Excellence
ISSN: 0945-6317
Projects: Future Ocean
Date Deposited: 30 Mar 2015 11:59
Last Modified: 30 Mar 2015 11:59
URI: http://eprints.uni-kiel.de/id/eprint/27205

Actions (login required)

View Item View Item